Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Atherosclerosis. 2014 Aug 12;236(2):360–365. doi: 10.1016/j.atherosclerosis.2014.07.026

Figure 2.

Figure 2

Kaplan-Meier analysis showing association of soluble fms-like tyrosine kinase-1 (sFlt-1) with cardiovascular events (A, log-rank test p=0.102) and mortality (B, log-rank test p=0.005) in 301 patients with CKD